Can Plasma Treat Factor XIII Deficiency Emergencies?

Yes, if you have experienced severe trauma or are experiencing a life-threatening bleed and your hospital does not have access to targeted Factor XIII concentrates (such as Corifact or Tretten), fresh frozen plasma or cryoprecipitate can be used ^[1]. Because Factor XIII deficiency often causes delayed bleeding—where a clot forms initially but breaks down hours or days later—you should seek emergency treatment immediately after a severe trauma, even if you are not visibly bleeding yet ^[2][3].

While purified concentrates are always the safest and most effective standard of care ^[3][4], both fresh frozen plasma and cryoprecipitate naturally contain Factor XIII and can provide necessary, life-saving clotting support when there are no other options available ^[1].

How Emergency Blood Products Work

Factor XIII concentrates are highly purified or lab-created treatments that deliver a concentrated dose of the missing clotting factor ^[5][6]. In an ideal setting, this is exactly what you should receive ^[4]. However, many local emergency departments do not routinely stock these rare medications.

If you need immediate stabilization and waiting for a specialty pharmacy transfer is not an option, doctors can use standard blood bank products that contain lower amounts of Factor XIII:

• Fresh Frozen Plasma (FFP): This is the liquid portion of human blood that has been frozen. It contains all the natural clotting factors found in the body, including Factor XIII ^[7][1].
• Cryoprecipitate: This is a concentrated preparation made from thawing fresh frozen plasma. Because it is concentrated, it holds a higher amount of Factor XIII in a much smaller amount of liquid ^[1][8][9].

Cryoprecipitate vs. Fresh Frozen Plasma

If forced to use an emergency backup, doctors generally prefer cryoprecipitate over fresh frozen plasma ^[7][9]. Because cryoprecipitate contains a higher concentration of Factor XIII per unit of volume, it requires far less fluid to reach the required factor levels to stop a bleed ^[1][8]. However, it is important to remember that because it is still derived from human plasma, cryoprecipitate carries the same infectious and allergic risks as fresh frozen plasma ^[3].

Risks and Drawbacks of Emergency Backups

While these backup therapies are life-saving, they come with significant risks compared to standard concentrates.

Fluid Overload and Lung Injury

The most severe immediate risk of using fresh frozen plasma for a Factor XIII emergency is Transfusion-Associated Circulatory Overload (TACO) ^[10][1]. This happens when a large volume of fluid is pumped into the bloodstream too quickly, overwhelming the heart and lungs and making it difficult to breathe ^[11][12][13]. Because Factor XIII is heavily diluted in fresh frozen plasma, it takes massive amounts of the liquid to deliver enough of the factor to stabilize a severe bleed ^[10]. Using cryoprecipitate reduces this risk because the required fluid volume is much smaller ^[9].

Another rare but serious risk is Transfusion-Related Acute Lung Injury (TRALI), a severe reaction where fluid builds up in the lungs unrelated to the volume of fluid given ^[11].

Risk of Infection and Allergic Reactions

Because both fresh frozen plasma and cryoprecipitate are donor-derived human blood products, they carry an inherent risk of transfusion-transmitted infections (viruses passed from the donor) and severe allergic reactions, including anaphylaxis ^[3][10]. While modern blood banking systems screen heavily for these risks, they cannot be reduced to zero ^[5][14].

In contrast, plasma-derived concentrates like Corifact undergo rigorous viral inactivation processes that make them exceptionally safe ^[3], and recombinant (lab-created) concentrates like Tretten completely eliminate the risk of human blood-borne infections ^[5][15][16].

Symptoms to Report Immediately

If you are receiving fresh frozen plasma or cryoprecipitate, notify a nurse or doctor immediately if you experience any of the following signs of a transfusion reaction:

• Sudden shortness of breath or wheezing
• Chest pain or tightness
• Hives, rash, or severe itching
• Swelling of the face, lips, or throat
• Sudden fever or chills

Dosing Complexity

Treating severe Factor XIII deficiency requires personalized dosing based on a patient’s weight and baseline factor levels ^[17][12]. Emergency blood products do not have perfectly standardized amounts of Factor XIII in every bag, making it harder for doctors to calculate the exact dose needed to stop the bleed ^[7][18].

Self-Advocacy in the Emergency Room

Because Factor XIII deficiency is exceptionally rare, many emergency room physicians may never have treated it. You are your own best advocate. If you are in an emergency setting without concentrates, you can tell the medical team:

“I have Factor XIII deficiency. If this hospital does not have targeted concentrates like Corifact or Tretten, standard protocol suggests using Cryoprecipitate rather than Fresh Frozen Plasma to replace my Factor XIII, because it significantly reduces my risk of dangerous fluid overload.”

The Good News: Factor XIII Lasts a Long Time

Factor XIII has an unusually long half-life—meaning the amount of time it takes for half of the medication to leave your body ^[19]. The active part of the factor remains in the bloodstream for roughly 7 to 14 days ^[19][17]. This means that if an emergency room successfully uses fresh frozen plasma or cryoprecipitate to stabilize a life-threatening bleed or severe trauma, it will likely keep you safe long enough for your medical team to either transfer you to a specialized hospital or order your preferred concentrate ^[19].